NCT00953446 Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma Status TERMINATED Phase NA
NCT00948688 Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas Status TERMINATED Phase PHASE1/PHASE2
NCT00942682 Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors Status COMPLETED Phase PHASE1
NCT00941759 Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer Status COMPLETED Phase N/A
NCT00936858 RAD001 for Patients With Radioiodine Refractory Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00936611 LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00928018 Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma Status COMPLETED Phase PHASE3
NCT00925652 Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer Status TERMINATED Phase PHASE2
NCT00916669 A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) Status WITHDRAWN Phase PHASE2
NCT00916630 Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) Status COMPLETED Phase PHASE1
NCT00916162 Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy Status COMPLETED Phase N/A
NCT00911820 Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00910000 Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00903968 Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00903162 Extended Endocrine Therapy for Premenopausal Women With Breast Cancer Status COMPLETED Phase PHASE2
NCT00895661 High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas Status COMPLETED Phase PHASE2
NCT00890500 Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Status COMPLETED Phase PHASE1
NCT00889187 Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00880464 Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer Status COMPLETED Phase PHASE1